161 related articles for article (PubMed ID: 33878964)
21. Sirolimus for the treatment of children with various complicated vascular anomalies.
Lackner H; Karastaneva A; Schwinger W; Benesch M; Sovinz P; Seidel M; Sperl D; Lanz S; Haxhija E; Reiterer F; Sorantin E; Urban CE
Eur J Pediatr; 2015 Dec; 174(12):1579-84. PubMed ID: 26040705
[TBL] [Abstract][Full Text] [Related]
22. Oral Sirolimus: An Option in the Management of Neonates with Life-Threatening Upper Airway Lymphatic Malformations.
Triana P; Miguel M; Díaz M; Cabrera M; López Gutiérrez JC
Lymphat Res Biol; 2019 Oct; 17(5):504-511. PubMed ID: 30985248
[No Abstract] [Full Text] [Related]
23. Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: A case series.
Le Sage S; David M; Dubois J; Powell J; McCuaig CC; Théorêt Y; Kleiber N
Pediatr Dermatol; 2018 Jul; 35(4):472-477. PubMed ID: 29790593
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review.
Freixo C; Ferreira V; Martins J; Almeida R; Caldeira D; Rosa M; Costa J; Ferreira J
J Vasc Surg; 2020 Jan; 71(1):318-327. PubMed ID: 31676179
[TBL] [Abstract][Full Text] [Related]
25. Single-center experience with sirolimus therapy for vascular malformations.
Yesil S; Tanyildiz HG; Bozkurt C; Cakmakci E; Sahin G
Pediatr Hematol Oncol; 2016 Apr; 33(3):219-25. PubMed ID: 27128161
[TBL] [Abstract][Full Text] [Related]
26. Successful Treatment of Fibro-Adipose Vascular Anomaly with Sirolimus.
Wang Z; Yan H; Ding Y; Gong Y; Ma Y; Yao W; Li K
J Pediatr Surg; 2023 Jul; 58(7):1337-1341. PubMed ID: 36898877
[TBL] [Abstract][Full Text] [Related]
27. Sirolimus in the Treatment of Vascular Anomalies.
Triana P; Dore M; Cerezo VN; Cervantes M; Sánchez AV; Ferrero MM; González MD; Lopez-Gutierrez JC
Eur J Pediatr Surg; 2017 Feb; 27(1):86-90. PubMed ID: 27723921
[No Abstract] [Full Text] [Related]
28. Preliminary results of the European multicentric phase III trial regarding sirolimus in slow-flow vascular malformations.
Seront E; Van Damme A; Legrand C; Bisdorff-Bresson A; Orcel P; Funck-Brentano T; Sevestre MA; Dompmartin A; Quere I; Brouillard P; Revencu N; De Bortoli M; Hammer F; Clapuyt P; Dumitriu D; Vikkula M; Boon LM
JCI Insight; 2023 Nov; 8(21):. PubMed ID: 37937645
[TBL] [Abstract][Full Text] [Related]
29. Oral rapamycin: an alternative in children with complicated vascular abnormalities.
Gómez Sánchez A; Redondo Sedano JV; Pérez Alonso V; Martí Carrera ME; Baro Fernández M; Palencia Pérez SI; Gallego Herrero MC; Gómez Fraile A; Delgado Muñoz MD
Cir Pediatr; 2020 Oct; 33(4):183-187. PubMed ID: 33016658
[TBL] [Abstract][Full Text] [Related]
30. The Use of Sirolimus for Treatment of Orbital Lymphatic Malformations: A Systematic Review.
Shoji MK; Shishido S; Freitag SK
Ophthalmic Plast Reconstr Surg; 2020; 36(3):215-221. PubMed ID: 31990892
[TBL] [Abstract][Full Text] [Related]
31. Fibroadipose vascular anomaly treated with sirolimus: Successful outcome in two patients.
Erickson J; McAuliffe W; Blennerhassett L; Halbert A
Pediatr Dermatol; 2017 Nov; 34(6):e317-e320. PubMed ID: 29144050
[TBL] [Abstract][Full Text] [Related]
32. Sirolimus for the treatment of complicated vascular anomalies in children.
Hammill AM; Wentzel M; Gupta A; Nelson S; Lucky A; Elluru R; Dasgupta R; Azizkhan RG; Adams DM
Pediatr Blood Cancer; 2011 Dec; 57(6):1018-24. PubMed ID: 21445948
[TBL] [Abstract][Full Text] [Related]
33. Sirolimus for management of complex vascular anomalies - A proposed dosing regimen for very young infants.
Czechowicz JA; Long-Boyle JR; Rosbe KW; Mathes EF; Frieden IJ; Shimano KA
Int J Pediatr Otorhinolaryngol; 2018 Feb; 105():48-51. PubMed ID: 29447818
[TBL] [Abstract][Full Text] [Related]
34. Clinical differences in sirolimus treatment with low target levels between children and adults with vascular malformations - A nationwide trial.
Harbers VEM; Zwerink LGJM; Rongen GA; Klein WM; van der Vleuten CJM; van Rijnsoever IMP; Gerdsen-Drury L; Flucke UE; Verhoeven BH; de Laat PCJ; van der Horst CMAM; Schultze Kool LJ; Te Loo DMWM
Clin Transl Sci; 2023 May; 16(5):781-796. PubMed ID: 36824030
[TBL] [Abstract][Full Text] [Related]
35. Medical management of vascular anomalies of the head and neck.
Léauté-Labrèze C
J Oral Pathol Med; 2022 Nov; 51(10):837-843. PubMed ID: 35668029
[TBL] [Abstract][Full Text] [Related]
36. Clinicoradiologic predictors of sclerotherapy response in low-flow vascular malformations.
Bagga B; Goyal A; Das A; Bhalla AS; Kandasamy D; Singhal M; Kairo A
J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):209-219.e2. PubMed ID: 32653406
[TBL] [Abstract][Full Text] [Related]
37. Successful Treatment of a Complex Vascular Malformation With Sirolimus and Surgical Resection.
Goldenberg DC; Carvas M; Adams D; Giannotti M; Gemperli R
J Pediatr Hematol Oncol; 2017 May; 39(4):e191-e195. PubMed ID: 27820120
[TBL] [Abstract][Full Text] [Related]
38. Incidence of major complication following embolo-sclerotherapy for upper and lower extremity vascular malformations.
Lim CS; Evans N; Kaur I; Papadopoulou A; Khalifa M; Tsui J; Hamilton G; Brookes J
Vascular; 2021 Feb; 29(1):69-77. PubMed ID: 32605532
[TBL] [Abstract][Full Text] [Related]
39. Topical sirolimus for the treatment of cutaneous manifestations of vascular anomalies: A case series.
Badia P; Ricci K; Gurria JP; Dasgupta R; Patel M; Hammill A
Pediatr Blood Cancer; 2020 Apr; 67(4):e28088. PubMed ID: 31930696
[TBL] [Abstract][Full Text] [Related]
40. Low flow vascular malformations of the head and neck: a study on brightness mode, color coded duplex and spectral Doppler sonography.
Eivazi B; Fasunla AJ; Hundt W; Wiegand S; Teymoortash A
Eur Arch Otorhinolaryngol; 2011 Oct; 268(10):1505-11. PubMed ID: 21327731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]